Common diabetes drug could help control rare Muscle-Wasting disease
NCT ID NCT05532813
Summary
This study is testing whether metformin, a medication commonly used for diabetes, can improve muscle function and control symptoms in adults with myotonic dystrophy type 1 (Steinert's disease). Researchers will compare metformin against a placebo in 142 participants over 12 months to see if it helps with walking, strength, breathing, and daily activities. The goal is to see if this existing drug can help manage this progressive muscle condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOTONIC DYSTROPHY 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neurology Department, Raymond-Poincaré hospital - APHP
RECRUITINGGarches, 92380, France
Conditions
Explore the condition pages connected to this study.